Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Eftimov

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Neurology|September 20, 2022
SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor NeuropathyAdája E Baars, Krista Kuitwaard, Laura C de Koning, et al.
Neurology|July 18, 2020
Nerve ultrasound for diagnosing chronic inflammatory neuropathy: A multicenter validation studyIngrid J T Herraets, H Stephan Goedee, Johan A Telleman, et al.
Neurology|June 4, 2025
Efficacy of Combined Aerobic Exercise and Coaching on Physical Fitness in People With Neuromuscular Diseases: A Randomized Clinical TrialSander Oorschot, Merel-Anne Brehm, Annerieke C van Groenestijn, et al.
BMC Neurology|October 25, 2024
Inflammatory Neuropathy Consortium base (INCbase): a protocol of a global prospective observational cohort study for the development of a prediction model for treatment response in chronic inflammatory demyelinating polyneuropathyMilou R Michael, Luuk Wieske, Jeffrey A Allen, et al.
BMJ Open|July 10, 2023
Treatment with add-on IVIg in Myositis Early In the diSease course May be sUperior to Steroids alone for reaching CLinical improvEment (TIME IS MUSCLE): study protocol of a phase-2 double-blind placebo-controlled randomised trialRenske G Kamperman, Johannes A Bogaards, Sanne W Evers, et al.
Neurology|June 16, 2026
Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating PolyradiculoneuropathyJeffrey A Allen, Filip Eftimov, Luis Querol, et al.
Frontiers in Neurology|November 28, 2022
Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccinationKoos P J van Dam, Laura Hogenboom, Eileen W Stalman, et al.
The Journal of Allergy and Clinical Immunology|March 1, 2023
Distinct dynamics of antigen-specific induction and differentiation of different CD11c<sup>+</sup>Tbet<sup>+</sup> B-cell subsetsJuulke Steuten, Amélie V Bos, Lisan H Kuijper, et al.
The Journal of Allergy and Clinical Immunology|November 6, 2022
Comprehensive overview of autoantibody isotype and subclass distributionMikhail Volkov, Mariateresa Coppola, Ruth Huizinga, et al.
Journal of Neuromuscular Diseases|September 6, 2024
A Likely Pathogenic variant in the <i>KBTBD13</i> Gene: A Case Series of Three Patients with Nemaline Myopathy Type 6Esmee S B van Kleef, Karlijn Bouman, Joery P F Molenaar, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Neurology|September 20, 2022
SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor NeuropathyAdája E Baars, Krista Kuitwaard, Laura C de Koning, et al.
Neurology|July 18, 2020
Nerve ultrasound for diagnosing chronic inflammatory neuropathy: A multicenter validation studyIngrid J T Herraets, H Stephan Goedee, Johan A Telleman, et al.
Neurology|June 4, 2025
Efficacy of Combined Aerobic Exercise and Coaching on Physical Fitness in People With Neuromuscular Diseases: A Randomized Clinical TrialSander Oorschot, Merel-Anne Brehm, Annerieke C van Groenestijn, et al.
BMC Neurology|October 25, 2024
Inflammatory Neuropathy Consortium base (INCbase): a protocol of a global prospective observational cohort study for the development of a prediction model for treatment response in chronic inflammatory demyelinating polyneuropathyMilou R Michael, Luuk Wieske, Jeffrey A Allen, et al.
BMJ Open|July 10, 2023
Treatment with add-on IVIg in Myositis Early In the diSease course May be sUperior to Steroids alone for reaching CLinical improvEment (TIME IS MUSCLE): study protocol of a phase-2 double-blind placebo-controlled randomised trialRenske G Kamperman, Johannes A Bogaards, Sanne W Evers, et al.
Neurology|June 16, 2026
Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating PolyradiculoneuropathyJeffrey A Allen, Filip Eftimov, Luis Querol, et al.
Frontiers in Neurology|November 28, 2022
Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccinationKoos P J van Dam, Laura Hogenboom, Eileen W Stalman, et al.
The Journal of Allergy and Clinical Immunology|March 1, 2023
Distinct dynamics of antigen-specific induction and differentiation of different CD11c<sup>+</sup>Tbet<sup>+</sup> B-cell subsetsJuulke Steuten, Amélie V Bos, Lisan H Kuijper, et al.
The Journal of Allergy and Clinical Immunology|November 6, 2022
Comprehensive overview of autoantibody isotype and subclass distributionMikhail Volkov, Mariateresa Coppola, Ruth Huizinga, et al.
Journal of Neuromuscular Diseases|September 6, 2024
A Likely Pathogenic variant in the <i>KBTBD13</i> Gene: A Case Series of Three Patients with Nemaline Myopathy Type 6Esmee S B van Kleef, Karlijn Bouman, Joery P F Molenaar, et al.
Pageof 10